Lymphomas represent the fifth most common cancer diagnosis.Therapies of lymphomas are moving away from the non-specific cytotoxicagent, toward more targeted approaches including immunotherapy.Immunotherapy approaches include monoclonal antibodies either alone orcombined with chemotherapy or radiotherapy and the use of cytokines andanti-lymphoma vaccines which are still under trial.